BELIEVE_IN_SCIENCE_LTD - Accounts


Company registration number 12716172 (England and Wales)
BELIEVE IN SCIENCE LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023
PAGES FOR FILING WITH REGISTRAR
BELIEVE IN SCIENCE LTD
BALANCE SHEET
AS AT
31 JULY 2023
31 July 2023
- 1 -
2023
2022
Notes
£
£
£
£
Fixed assets
Intangible assets
4
69,808
64,665
Tangible assets
5
955,810
562,962
1,025,618
627,627
Current assets
Stocks
75,981
118,101
Debtors
6
1,168,840
763,104
Cash at bank and in hand
2,452,451
6,428,396
3,697,272
7,309,601
Creditors: amounts falling due within one year
7
(787,362)
(503,002)
Net current assets
2,909,910
6,806,599
Total assets less current liabilities
3,935,528
7,434,226
Creditors: amounts falling due after more than one year
8
(383,819)
(86,611)
Net assets
3,551,709
7,347,615
Capital and reserves
Called up share capital
9
2
2
Share premium account
10,348,253
10,129,972
Profit and loss reserves
(6,796,546)
(2,782,359)
Total equity
3,551,709
7,347,615

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

BELIEVE IN SCIENCE LTD
BALANCE SHEET (CONTINUED)
AS AT
31 JULY 2023
31 July 2023
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 24 April 2024 and are signed on its behalf by:
Mr A Fletcher
Director
Company registration number 12716172 (England and Wales)
BELIEVE IN SCIENCE LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023
- 3 -
1
Accounting policies
Company information

Believe in Science Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 5-7 Cranwood Street, C/O Jeffreys Henry, London, England, EC1V 9EE.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

1.3
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

BELIEVE IN SCIENCE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2023
1
Accounting policies
(Continued)
- 4 -

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Trademark
Over 10 years
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
20% Straight line
Plant and equipment
20% Straight line
Fixtures and fittings
33.33% Straight line
Computers
33.33% Straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

BELIEVE IN SCIENCE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2023
1
Accounting policies
(Continued)
- 5 -

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

BELIEVE IN SCIENCE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2023
1
Accounting policies
(Continued)
- 6 -
1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss

on a straight line basis over the term of the relevant lease except where another more systematic basis is

more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.14
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
46
28
BELIEVE IN SCIENCE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2023
- 7 -
4
Intangible fixed assets
Trademark
£
Cost
At 1 August 2022
73,359
Additions
13,186
At 31 July 2023
86,545
Amortisation and impairment
At 1 August 2022
8,694
Amortisation charged for the year
8,043
At 31 July 2023
16,737
Carrying amount
At 31 July 2023
69,808
At 31 July 2022
64,665
5
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 August 2022
197,566
460,124
657,690
Additions
-
0
956,388
956,388
Disposals
(7,270)
(195,805)
(203,075)
Transfers
-
0
(111,772)
(111,772)
At 31 July 2023
190,296
1,108,935
1,299,231
Depreciation and impairment
At 1 August 2022
26,571
68,157
94,728
Depreciation charged in the year
39,513
244,280
283,793
Eliminated in respect of disposals
(1,591)
(31,646)
(33,237)
Transfers
-
0
(1,863)
(1,863)
At 31 July 2023
64,493
278,928
343,421
Carrying amount
At 31 July 2023
125,803
830,007
955,810
At 31 July 2022
170,995
391,967
562,962
BELIEVE IN SCIENCE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2023
- 8 -
6
Debtors
2023
2022
Amounts falling due within one year:
£
£
Trade debtors
262,349
134,532
Corporation tax recoverable
260,349
125,098
Other debtors
646,142
503,474
1,168,840
763,104
7
Creditors: amounts falling due within one year
2023
2022
£
£
Trade creditors
204,454
129,023
Taxation and social security
62,784
70,651
Other creditors
520,124
303,328
787,362
503,002

The directors consider that the carrying amount of trade payables approximates to their fair value.

8
Creditors: amounts falling due after more than one year
2023
2022
£
£
Other creditors
383,819
86,611
9
Called up share capital
2023
2022
2023
2022
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 0.01p each
25,093
24,827
2
2

 

 

2023-07-312022-08-01falseCCH SoftwareCCH Accounts Production 2024.100No description of principal activityMs C DolanMr A FletcherMr J Mitchellfalsefalse127161722022-08-012023-07-31127161722023-07-31127161722022-07-3112716172core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2023-07-3112716172core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2022-07-3112716172core:LandBuildings2023-07-3112716172core:OtherPropertyPlantEquipment2023-07-3112716172core:LandBuildings2022-07-3112716172core:OtherPropertyPlantEquipment2022-07-3112716172core:CurrentFinancialInstrumentscore:WithinOneYear2023-07-3112716172core:CurrentFinancialInstrumentscore:WithinOneYear2022-07-3112716172core:Non-currentFinancialInstrumentscore:AfterOneYear2023-07-3112716172core:Non-currentFinancialInstrumentscore:AfterOneYear2022-07-3112716172core:CurrentFinancialInstruments2023-07-3112716172core:CurrentFinancialInstruments2022-07-3112716172core:ShareCapital2023-07-3112716172core:ShareCapital2022-07-3112716172core:SharePremium2023-07-3112716172core:SharePremium2022-07-3112716172core:RetainedEarningsAccumulatedLosses2023-07-3112716172core:RetainedEarningsAccumulatedLosses2022-07-3112716172bus:Director22022-08-012023-07-3112716172core:IntangibleAssetsOtherThanGoodwill2022-08-012023-07-3112716172core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2022-08-012023-07-3112716172core:LeaseholdImprovements2022-08-012023-07-3112716172core:PlantMachinery2022-08-012023-07-3112716172core:FurnitureFittings2022-08-012023-07-3112716172core:ComputerEquipment2022-08-012023-07-31127161722021-08-012022-07-3112716172core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2022-07-3112716172core:LandBuildings2022-07-3112716172core:OtherPropertyPlantEquipment2022-07-31127161722022-07-3112716172core:LandBuildings2022-08-012023-07-3112716172core:OtherPropertyPlantEquipment2022-08-012023-07-3112716172core:WithinOneYear2023-07-3112716172core:WithinOneYear2022-07-3112716172core:Non-currentFinancialInstruments2023-07-3112716172core:Non-currentFinancialInstruments2022-07-3112716172bus:PrivateLimitedCompanyLtd2022-08-012023-07-3112716172bus:SmallCompaniesRegimeForAccounts2022-08-012023-07-3112716172bus:FRS1022022-08-012023-07-3112716172bus:AuditExempt-NoAccountantsReport2022-08-012023-07-3112716172bus:Director12022-08-012023-07-3112716172bus:Director32022-08-012023-07-3112716172bus:FullAccounts2022-08-012023-07-31xbrli:purexbrli:sharesiso4217:GBP